Cambrex completed its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. The expansion doubles the facility’s manufacturing capacity with new state-of-the-art analytical and chemical development labs, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work centers and 2,000 Liter reactors. The capabilities at the High Point facility complemen...